The board of directors for Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has appointed Bryan Hanson president and chief executive officer. Hanson, who also joins the company’s board, succeeds David Dvorak, who stepped down in July.
Hanson most recently served as executive vice president and president of Minnesota-based Medtronic’s Minimally Invasive Therapies Group. Larry Glasscock, chairman of the Zimmer Biomet Board of Directors, says Hanson was chosen after a lengthy search.
"Bryan is a proven executive with a track record of successfully leading, growing and transforming global medical device businesses to achieve higher levels of innovation, commercial success and profitability," said Glasscock. "This leadership announcement comes at an important time in Zimmer Biomet’s history, and we look forward to working closely with Bryan to further leverage our leading portfolio of technologies, solutions and personalized services to enhance stockholder value."
The company says Daniel Florin, who has served as interim CEO since Dvorak stepped down, will continue in his role as senior vice president and chief financial officer.